As shown in Figure 3, sensitization of the prostate cancer cell lines LNCaP (androgen-receptor positive) or PC3 (androgen-receptor negative) with BaxM159 significantly reduced the half-maximal effective concentration (EC50) of mitoxantrone by 40% and 30%, respectively (Figure 3A and Figure 3B). The gene discussed is AR; the disease is prostate carcinoma.